Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

This study has been terminated.
(low accrual)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: November 16, 2009
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)